Johnson & Johnson on Wednesday took another step forward in establishing two independent companies with the announcement of Kenvue as the name for the planned new consumer health company.
Kenvue (pronounced ken·view), is inspired by two ideas: “ken” – meaning knowledge, an English word primarily used in Scotland, and “vue,” referencing sight.
“Unveiling the Kenvue brand is a defining moment for our stakeholders and an important part of the planned separation,” said Thibaut Mongon, CEO-designate of Kenvue. “We breathe life into some of the world’s most iconic and beloved brands every day, so we harnessed that same expertise, love, and energy into developing our new corporate identity.”
Kenvue will become a standalone leading global consumer health company in 2023, subject to legal requirements. Its portfolio of brands include Aveeno, Band-Aid brand adhesive bandages, Listerine, Neutrogena, Tylenol, Johnson’s and Dr. Ci:Labo.
Mongon added that Kenvue’s purpose, Realize the Extraordinary Power of Everyday Care, will guide the company’s actions and long-term aspirations.
“We believe that daily self-care rituals add up over time and have a profound cumulative impact on your wellbeing. This is the extraordinary power of everyday care. And our work is to put that power into the hands of consumers around the world,” he said.
The new logo centers on the “K” symbol, embodying the company’s strengths – the geometry of the rectangle representing scientific precision and the round edges evoking the warmth of care. The corporate name is depicted in a distinctive logotype in a rich green. The company said the strong, distinctive color will work in harmony with the multicolored palette of its portfolio of well-known brands.
“Today’s announcement is another milestone for the Consumer Health business. Kenvue is poised to thrive as a standalone company with a leading portfolio of brands consumers love and trust. I’m confident in this team and excited to see what the future holds,” Joaquin Duato, chief executive of Johnson & Johnson, commented.
